Precision Medicine Regulatory Research Roadmap Set Out In Perspective Article

A recent perspectives article appearing in Science Translational Medicine described several regulatory research challenges that remain in the way of fulfilling the diagnostic testing potential of next-generation sequencing. Stanford University’s Russ Altman and his colleagues outlined nine main challenges that must be tackled if next-generation-based diagnostic testing, under the broader umbrella of the Precision Medicine Initiative, is to become routine.